Myosmine

CAS No. 532-12-7

Myosmine( —— )

Catalog No. M20968 CAS No. 532-12-7

Myosmine is a minor tobacco alkaloid that is structurally related to nicotine.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 37 Get Quote
200MG 60 Get Quote
500MG 107 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Myosmine
  • Note
    Research use only, not for human use.
  • Brief Description
    Myosmine is a minor tobacco alkaloid that is structurally related to nicotine.
  • Description
    Myosmine is a minor tobacco alkaloid that is structurally related to nicotine.
  • In Vitro
    Myosmine is easily nitrosated, yielding 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) and the esophageal tobacco carcinogen N'-nitrosonornicotine.
  • In Vivo
    Myosmine (0.001, 0.005, 0.5, and 50 micromol/kg; oral; in Wistar rats) causes a higher percentage of the radioactivity excreted in urine (86.2% and 88.9%) at the two lower doses (0.001 and 0.005 micromol/kg),as compared with the higher doses (0.5 and 50 micromol/kg), where only 77.8% and 75.4% of the dose is found in urine.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    532-12-7
  • Formula Weight
    146.19
  • Molecular Formula
    C9H10N2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : ≥ 100 mg/mL (684.04 mM))
  • SMILES
    c1cncc(C2=NCCC2)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zwickenpflug W Tyroller S Richter E . Metabolism of myosmine in Wistar rats.[J]. Drug Metabolism & Disposition the Biological Fate of Chemicals 2005 33(11):1648.
molnova catalog
related products
  • 3-Epiursolic acid

    3-Epiursolic acid may have antiinflammatory activity, it shows inhibition on Cathepsins L (catL), the IC50 value of 6.5 μM, cathepsins L (catL) and B play an important role in tumor progression and have been considered promising therapeutic targets in the development of novel anticancer agents.

  • Casegravol

    Casegravol shows antiproliferative activity against human gastric adenocarcinoma (MK-1), human uterus carcinoma (HeLa), and murine melanoma (B16F10) cells.

  • Glycogen phosphoryla...

    Glycogen phosphorylase-IN-1 is a selective and potent inhibitor of human hepatic glycogen phosphorylase (hlGPa) with inhibitory effects on hlGPa activity and on hepatocyte glycogen-derived glucose production, and can be used in the study of type 2 diabetes mellitus and canine lupus.